Lexington, MA - February 9, 2006 - Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule drugs to treat severe medical conditions, today announced that it will present at the BIO CEO conference at the Waldorf Astoria Hotel in New York City on Wednesday, February 15, 2006 at 3:00 pm EST in the Conrad Suite.
Synta president and chief executive officer, Safi Bahcall, Ph.D., will provide an overview of the company and its programs.
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule drugs to extend and enhance the lives of patients with severe medical conditions, including chronic inflammatory disease and cancer. Synta currently has three drug candidates in human clinical trials, as well as a diverse pipeline of internally developed discovery programs. For more information, see www.syntapharma.com.